Total Payments
$49,637
2024 Payments
$449.34
Companies
52
Transactions
655
Medicare Patients
2,251
Medicare Billing
$495,747
Payment Breakdown by Category
Other$24,755 (49.9%)
Food & Beverage$16,385 (33.0%)
Travel$6,120 (12.3%)
Consulting$1,688 (3.4%)
Education$689.67 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $19,500 | 11 | 39.3% |
| Food and Beverage | $16,385 | 615 | 33.0% |
| Travel and Lodging | $6,120 | 22 | 12.3% |
| Compensation for serving as faculty or as a speaker for a medical education program | $4,125 | 3 | 8.3% |
| Consulting Fee | $1,688 | 2 | 3.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,130 | 1 | 2.3% |
| Education | $689.67 | 1 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Nevro Corp. | $38,569 | 209 | $0 (2024) |
| Medtronic USA, Inc. | $1,834 | 48 | $0 (2020) |
| Vertos Medical, Inc. | $1,229 | 8 | $0 (2024) |
| Abbott Laboratories | $831.42 | 20 | $0 (2023) |
| ABBVIE INC. | $717.81 | 48 | $0 (2024) |
| Medtronic, Inc. | $603.94 | 8 | $0 (2023) |
| Flexion Therapeutics, Inc. | $553.87 | 30 | $0 (2020) |
| Boston Scientific Corporation | $552.59 | 23 | $0 (2023) |
| Depomed, Inc. | $399.36 | 15 | $0 (2017) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $394.58 | 28 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $449.34 | 20 | Nevro Corp. ($175.83) |
| 2023 | $875.17 | 44 | Nevro Corp. ($307.61) |
| 2022 | $2,337 | 56 | Nevro Corp. ($1,786) |
| 2021 | $7,673 | 79 | Nevro Corp. ($6,431) |
| 2020 | $4,176 | 73 | Nevro Corp. ($3,407) |
| 2019 | $23,241 | 141 | Nevro Corp. ($21,344) |
| 2018 | $7,132 | 165 | Nevro Corp. ($4,627) |
| 2017 | $3,754 | 77 | Vertos Medical, Inc. ($1,176) |
All Payment Transactions
655 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $25.53 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/25/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.54 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $29.76 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/11/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $31.86 | General |
| Category: Spinal Cord Stimulator | ||||||
| 08/12/2024 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Orthopedic | ||||||
| 07/22/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $32.73 | General |
| Category: NEUROSCIENCE | ||||||
| 05/15/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $31.98 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/22/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: NEUROSCIENCE | ||||||
| 03/22/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $34.71 | General |
| Category: Spinal Cord Stimulator | ||||||
| 03/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $2.32 | General |
| Category: NEUROSCIENCE | ||||||
| 03/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $10.35 | General |
| Category: NEUROSCIENCE | ||||||
| 03/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.76 | General |
| Category: NEUROSCIENCE | ||||||
| 02/16/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: NEUROSCIENCE | ||||||
| 02/02/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $3.84 | General |
| Category: Spinal Cord Stimulator | ||||||
| 01/29/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $28.41 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $28.64 | General |
| Category: Spinal Cord Stimulator | ||||||
| 01/22/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $45.29 | General |
| Category: Spinal Cord Stimulator | ||||||
| 01/18/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $9.76 | General |
| Category: Spinal Cord Stimulator | ||||||
| 01/17/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $41.12 | General |
| Category: PAIN MANAGEMENT | ||||||
| 01/11/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Spinal Cord Stimulator | ||||||
| 12/22/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Spinal Cord Stimulator | ||||||
| 12/20/2023 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $29.96 | General |
| Category: NEUROSCIENCE | ||||||
| 12/08/2023 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2023 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.54 | General |
| Category: NEUROSCIENCE | ||||||
| 10/12/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Spinal Cord Stimulator | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 673 | 2,222 | $527,190 | $131,907 |
| 2022 | 10 | 571 | 2,249 | $534,010 | $131,849 |
| 2021 | 9 | 541 | 1,963 | $487,215 | $129,203 |
| 2020 | 10 | 466 | 1,921 | $391,417 | $102,788 |
Total Patients
2,251
Total Services
8,355
Medicare Billing
$495,747
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 160 | 849 | $343,845 | $79,959 | 23.3% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 69 | 94 | $74,260 | $22,090 | 29.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 81 | 81 | $42,120 | $10,412 | 24.7% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 15 | 20 | $11,300 | $4,046 | 35.8% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 15 | 18 | $15,390 | $3,656 | 23.8% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 152 | 274 | $10,960 | $3,306 | 30.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 25 | 53 | $10,600 | $3,273 | 30.9% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 18 | 24 | $8,520 | $2,177 | 25.6% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 15 | 20 | $5,800 | $2,166 | 37.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 108 | 771 | $3,855 | $649.31 | 16.8% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 15 | 18 | $540.00 | $172.38 | 31.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 140 | 832 | $336,960 | $80,244 | 23.8% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2022 | 45 | 70 | $55,300 | $16,518 | 29.9% |
| J7324 | Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | Office | 2022 | 13 | 76 | $49,400 | $8,960 | 18.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 70 | 70 | $36,400 | $8,878 | 24.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 31 | 72 | $14,400 | $4,720 | 32.8% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2022 | 17 | 20 | $11,300 | $3,890 | 34.4% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 132 | 253 | $10,120 | $3,113 | 30.8% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2022 | 21 | 29 | $10,295 | $2,797 | 27.2% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2022 | 17 | 20 | $5,800 | $2,010 | 34.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 85 | 807 | $4,035 | $719.44 | 17.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 153 | 874 | $341,510 | $86,729 | 25.4% |
| 64483 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance, single level | Office | 2021 | 45 | 74 | $57,865 | $17,695 | 30.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 64 | 64 | $33,040 | $8,198 | 24.8% |
| 64493 | Injections of lower or sacral spine facet joint using imaging guidance, single level | Office | 2021 | 19 | 27 | $15,165 | $5,009 | 33.0% |
About Shervin Harandi
Shervin Harandi is a Anesthesiology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2012. The National Provider Identifier (NPI) number assigned to this provider is 1063771509.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Shervin Harandi has received a total of $49,637 in payments from pharmaceutical and medical device companies, with $449.34 received in 2024. These payments were reported across 655 transactions from 52 companies. The most common payment nature is "Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program" ($19,500).
As a Medicare-enrolled provider, Harandi has provided services to 2,251 Medicare beneficiaries, totaling 8,355 services with total Medicare billing of $495,747. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Anesthesiology
- Other Specialties Pain Medicine, Interventional Pain Medicine
- Location Houston, TX
- Active Since 05/03/2012
- Last Updated 06/12/2019
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1063771509
Products in Payments
- Senza Spinal Cord Stimulation System (Device) $29,869
- Omnia (Device) $8,217
- mild Device Kit (Device) $1,229
- Zilretta (Drug) $712.35
- AUTOFILL (Device) $687.50
- SYNCHROMED (Device) $505.05
- Senza (Device) $483.44
- Nucynta (Drug) $393.82
- DRG IPGs (Device) $390.53
- BOTOX (Biological) $354.08
- RELISTOR ORAL (Drug) $325.87
- INTELLIS (Device) $291.09
- UBRELVY (Drug) $278.48
- QULIPTA (Drug) $274.31
- Horizant (Drug) $251.09
- XTAMPZA (Drug) $237.72
- LYRICA (Drug) $224.81
- Proclaim Family of SCS IPGs (Device) $221.90
- MYSTIM (Device) $214.14
- PRIALT (Drug) $208.85
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Houston
Tong Gan, M.d, M.D
Anesthesiology — Payments: $1.1M
Anesthesiology $1.1M
Gabriel Mena, M.d, M.D
Anesthesiology — Payments: $681,229
Anesthesiology $681,229
Harold Minkowitz, M.d, M.D
Anesthesiology — Payments: $316,628
Anesthesiology $316,628
Dr. David Leiman, M.d, M.D
Anesthesiology — Payments: $207,636
Anesthesiology $207,636
Ioannis Skaribas, Md, MD
Anesthesiology — Payments: $157,974
Anesthesiology $157,974
Dr. Jaideep Mehta, Md, Mba, MD, MBA
Anesthesiology — Payments: $143,064
Anesthesiology $143,064